Back to search

Article

ObLiGaRe doxycycline Inducible (ODIn) Cas9 system driving pre-clinical drug discovery, from design to cancer treatment

2020-04-07

Abstract excerpt

<h4>ABSTRACT</h4> The CRISPR-Cas9 system has increased the speed and precision of genetic editing in cells and animals. However, model generation for drug development is still expensive and time-consuming, demanding more target flexibility and faster turnaround times with high reproducibility. We have generated a tightly controlled ObLiGaRe doxycycline inducible SpCas9 (ODInCas9) transgene. Targeted ObLiGaRe resu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf3f40c1-cbcc-5f87-b19c-7535ff3afcd8
DOI
10.1101/2020.04.06.028803
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ObLiGaRe doxycycline Inducible (ODIn) Cas9 system driving pre-clinical drug discovery, from design to cancer treatmentDOI 10.1101/2020.04.06.028803
Select a neighboring publication to make it the new centre.